228 related articles for article (PubMed ID: 17204323)
1. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors.
Goto T; Nakao K; Gunjigake KK; Kido MA; Kobayashi S; Tanaka T
Neuropeptides; 2007 Feb; 41(1):25-31. PubMed ID: 17204323
[TBL] [Abstract][Full Text] [Related]
2. Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis.
Azuma H; Kido J; Ikedo D; Kataoka M; Nagata T
J Periodontol; 2004 Jul; 75(7):974-81. PubMed ID: 15341355
[TBL] [Abstract][Full Text] [Related]
3. Galanin treatment offsets the inhibition of bone formation and downregulates the increase in mouse calvarial expression of TNFalpha and GalR2 mRNA induced by chronic daily injections of an injurious vehicle.
McDonald AC; Schuijers JA; Gundlach AL; Grills BL
Bone; 2007 Apr; 40(4):895-903. PubMed ID: 17157570
[TBL] [Abstract][Full Text] [Related]
4. Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells.
Tran MT; Lausch RN; Oakes JE
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3871-7. PubMed ID: 11053288
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
6. Tachykinins and tachykinin receptors in bone.
Goto T; Tanaka T
Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
[TBL] [Abstract][Full Text] [Related]
7. Orexin B inhibits proliferation and stimulates specialized function of cultured rat calvarial osteoblast-like cells.
Ziolkowska A; Rucinski M; Tyczewska M; Malendowicz LK
Int J Mol Med; 2008 Dec; 22(6):749-55. PubMed ID: 19020772
[TBL] [Abstract][Full Text] [Related]
8. Immature osteoblastic cells express the pro-alpha2(XI) collagen gene during bone formation in vitro and in vivo.
Urabe K; Jingushi S; Ikenoue T; Okazaki K; Sakai H; Li C; Iwamoto Y
J Orthop Res; 2001 Nov; 19(6):1013-20. PubMed ID: 11780999
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells.
Matayoshi T; Goto T; Fukuhara E; Takano H; Kobayashi S; Takahashi T
Biochem Biophys Res Commun; 2005 Feb; 327(3):756-64. PubMed ID: 15649411
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
[TBL] [Abstract][Full Text] [Related]
11. Collagen cross-linking influences osteoblastic differentiation.
Turecek C; Fratzl-Zelman N; Rumpler M; Buchinger B; Spitzer S; Zoehrer R; Durchschlag E; Klaushofer K; Paschalis EP; Varga F
Calcif Tissue Int; 2008 May; 82(5):392-400. PubMed ID: 18488133
[TBL] [Abstract][Full Text] [Related]
12. Dlx5 regulation of mouse osteoblast differentiation mediated by avian retrovirus vector.
Erceg I; Tadić T; Kronenberg MS; Marijanović I; Lichtler AC
Croat Med J; 2003 Aug; 44(4):407-11. PubMed ID: 12950142
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation.
Danjo A; Yamaza T; Kido MA; Shimohira D; Tsukuba T; Kagiya T; Yamashita Y; Nishijima K; Masuko S; Goto M; Tanaka T
Biochem Biophys Res Commun; 2007 Aug; 360(1):199-204. PubMed ID: 17592728
[TBL] [Abstract][Full Text] [Related]
14. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
15. Substance P regulates PTH secretion through the neurokinin-1 receptor.
Galvin RJ; Babbey LE; Hipskind PA; Lamar T; George CA; Baez M; Gitter BD
Biochem Biophys Res Commun; 2000 Apr; 270(1):230-4. PubMed ID: 10733932
[TBL] [Abstract][Full Text] [Related]
16. Smad3 differently affects osteoblast differentiation depending upon its differentiation stage.
Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
Horm Metab Res; 2006 Nov; 38(11):740-5. PubMed ID: 17111301
[TBL] [Abstract][Full Text] [Related]
17. Substance P and its receptors in bone metabolism.
Liu D; Jiang LS; Dai LY
Neuropeptides; 2007 Oct; 41(5):271-83. PubMed ID: 17655927
[TBL] [Abstract][Full Text] [Related]
18. Cultured rat calvarial osteoblast-like cells are provided with orexin type 1 receptors.
Ziolkowska A; Rucinski M; Tortorella C; Tyczewska M; Nussdorfer GG; Malendowicz LK
Int J Mol Med; 2007 Dec; 20(6):779-82. PubMed ID: 17982683
[TBL] [Abstract][Full Text] [Related]
19. Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo.
Aghaloo TL; Amantea CM; Cowan CM; Richardson JA; Wu BM; Parhami F; Tetradis S
J Orthop Res; 2007 Nov; 25(11):1488-97. PubMed ID: 17568450
[TBL] [Abstract][Full Text] [Related]
20. Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis.
Opolka A; Straub RH; Pasoldt A; Grifka J; Grässel S
Arthritis Rheum; 2012 Mar; 64(3):729-39. PubMed ID: 22042746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
